Max Healthcare Institute Ltd
NSE:MAXHEALTH
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
601.65
1 079.9
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one MAXHEALTH stock under the Base Case scenario is 638.32 INR. Compared to the current market price of 999.95 INR, Max Healthcare Institute Ltd is Overvalued by 36%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Max Healthcare Institute Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for MAXHEALTH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Max Healthcare Institute Ltd. is a leading player in India’s rapidly evolving healthcare sector, renowned for its commitment to high-quality medical care and advanced technology. Founded in 2000, the company operates a robust network of multi-specialty hospitals and clinics, catering to a diverse patient population across urban and semi-urban regions. With a focus on patient-centric services, Max Healthcare has garnered a stellar reputation for its expertise in critical care, cardiology, oncology, and orthopedics. The institution is backed by a strong management team with extensive experience in healthcare and business, positioning it well to navigate the challenges of the industry while cap...
Max Healthcare Institute Ltd. is a leading player in India’s rapidly evolving healthcare sector, renowned for its commitment to high-quality medical care and advanced technology. Founded in 2000, the company operates a robust network of multi-specialty hospitals and clinics, catering to a diverse patient population across urban and semi-urban regions. With a focus on patient-centric services, Max Healthcare has garnered a stellar reputation for its expertise in critical care, cardiology, oncology, and orthopedics. The institution is backed by a strong management team with extensive experience in healthcare and business, positioning it well to navigate the challenges of the industry while capitalizing on the growing demand for quality healthcare services in India.
For investors, Max Healthcare represents an attractive opportunity, given the company’s strategic initiatives to expand its footprint and enhance service quality. As the healthcare landscape in India grows, propelled by rising income levels and an increasing focus on health and wellness, Max Healthcare's expansion plans—including new hospitals and technological advancements—suggest a promising trajectory for revenue growth. The company's innovative approach, combined with a solid operational framework, not only assures patients of comprehensive care but also creates value for shareholders. By investing in Max Healthcare, stakeholders can position themselves to benefit from the burgeoning healthcare market in India, characterized by increasing consumer spending on health services and a favorable regulatory environment.
Max Healthcare Institute Ltd. is one of the prominent healthcare providers in India, with a focus on delivering high-quality medical services. The core business segments of Max Healthcare typically include the following:
-
Hospitals and Healthcare Services: Max Healthcare operates a network of multi-specialty hospitals that provide a wide range of medical services. This segment includes diagnostics, inpatient and outpatient services, and specialized care in areas such as cardiology, oncology, orthopedics, neurology, and more.
-
Diagnostic Services: The company offers comprehensive diagnostic services, including pathology, radiology, and imaging services. These are essential for the diagnosis and treatment of various health conditions.
-
Telemedicine: With the rise of digital healthcare, Max Healthcare has expanded into telemedicine services, allowing patients to consult healthcare professionals remotely. This segment includes online consultations and remote monitoring of patients.
-
Health Insurance: While primarily focused on healthcare delivery, Max Healthcare may also offer health insurance products or partnerships to provide financial coverage for medical treatment, facilitating easier access to healthcare services for patients.
-
Health and Wellness Programs: This segment encompasses various preventive care initiatives, health check-ups, and wellness programs aimed at promoting a healthier lifestyle among patients.
-
Pharmacy Services: Max Healthcare may include in-house pharmacy services that provide patients with easy access to medications and health-related products within their facility.
Each of these segments contributes to Max Healthcare's overall mission of delivering quality healthcare solutions while focusing on patient satisfaction and clinical excellence. The integration of technology and patient-centric services also plays a vital role in their operational strategy.
Max Healthcare Institute Ltd, as one of the leading healthcare providers in India, possesses several unique competitive advantages that help it stand out among its rivals:
-
Comprehensive Care Network: Max Healthcare operates a wide network of multi-specialty hospitals and clinics, providing a range of services across various medical disciplines. This comprehensive offering enables them to attract a diverse patient base.
-
Strong Brand Reputation: With a focus on quality care and customer service, Max Healthcare has built a strong brand reputation over the years. Trust and recognition in the healthcare sector can lead to patient loyalty and referrals.
-
Advanced Healthcare Technology: Max Healthcare invests in state-of-the-art medical technology and equipment, which enhances the quality of care provided. Advanced technological capabilities can lead to better treatment outcomes, which is a vital consideration for patients.
-
Skilled Workforce: The organization employs highly qualified doctors, nurses, and healthcare professionals who are recognized for their expertise. Their ability to attract and retain top talent contributes significantly to the quality of care provided.
-
Accreditations and Certifications: Max Healthcare facilities typically pursue and maintain various national and international accreditations (like NABH and JCI), which not only enhance its reputation but also assure patients of the quality of services.
-
Patient-Centric Approach: The institution emphasizes a patient-centric approach, focusing on personalized care, convenience, and enhanced patient experience. This can lead to higher patient satisfaction, loyalty, and positive word-of-mouth.
-
Strategic Partnerships: Collaborations with various healthcare networks, insurance companies, and technology providers can give Max Healthcare an edge in terms of service delivery and operational efficiencies.
-
Innovative Healthcare Solutions: Max Healthcare's focus on telemedicine and digital health initiatives allows them to reach a broader audience and cater to the growing demand for more accessible healthcare solutions.
-
Research and Training Programs: Having educational and training programs for healthcare professionals helps to foster a culture of continuous learning and improvement, keeping them at the forefront of medical advancements.
-
Location: The strategic location of its facilities in major metropolitan areas allows Max Healthcare to tap into a larger patient base.
These advantages position Max Healthcare favorably in the competitive landscape, enabling it to deliver exceptional healthcare services and maintain a strong market presence.
Max Healthcare Institute Ltd, like many players in the healthcare sector, faces a variety of risks and challenges that could impact its business operations in the near future. Here are some key risks and challenges to consider:
-
Regulatory Environment: The healthcare industry is heavily regulated, and changes in regulations or policies could affect operational processes, costs, and service offerings. Compliance with local, national, and international standards is critical.
-
Competition: The healthcare sector is competitive, with numerous players emerging in various segments. Increased competition from established players and new entrants can impact market share and pricing strategies.
-
Economic Conditions: Economic downturns can reduce discretionary spending, impacting patient volumes in non-critical care services. A shift in the economic landscape could influence patient attendance and insurance coverage.
-
Technological Disruption: Rapid advancements in medical technology and telemedicine require continuous investment and adaptation. Failure to keep pace with technological progress can lead to obsolescence.
-
Healthcare Costs: Rising costs of healthcare services and potential changes in insurance reimbursement models can affect profitability. Increasing operational costs need to be managed effectively.
-
Talent Management: Recruiting and retaining skilled healthcare professionals is a significant challenge. A shortage of qualified personnel can affect service delivery and patient satisfaction.
-
Pandemic Preparedness: As evidenced by the COVID-19 crisis, healthcare institutions must be prepared for future pandemics or public health emergencies. Inadequate preparedness could lead to operational disruptions and financial losses.
-
Patient Safety and Quality of Care: Maintaining high standards of patient care is essential. Any incidents related to patient safety can lead to reputational damage and legal liabilities.
-
Supply Chain Risks: Disruptions in the supply chain for medical supplies, pharmaceuticals, and equipment can hinder operational efficiency and increase costs.
-
Market Dynamics: Changes in demographic trends, consumer preferences, and health coverage models can affect demand for services and necessitate shifts in strategy.
Navigating these risks effectively will require strategic planning, investment in technology, a focus on patient care, and regulatory compliance. Continuous monitoring of the external environment and adaptability will be crucial for Max Healthcare Institute Ltd’s sustained success.
Revenue & Expenses Breakdown
Max Healthcare Institute Ltd
Balance Sheet Decomposition
Max Healthcare Institute Ltd
Current Assets | 17.1B |
Cash & Short-Term Investments | 11.4B |
Receivables | 4.7B |
Other Current Assets | 989.6m |
Non-Current Assets | 102.9B |
Long-Term Investments | 3B |
PP&E | 36.9B |
Intangibles | 55.8B |
Other Non-Current Assets | 7.2B |
Current Liabilities | 12.5B |
Accounts Payable | 6.8B |
Short-Term Debt | 887.9m |
Other Current Liabilities | 4.8B |
Non-Current Liabilities | 23.4B |
Long-Term Debt | 11.9B |
Other Non-Current Liabilities | 11.5B |
Earnings Waterfall
Max Healthcare Institute Ltd
Revenue
|
56.6B
INR
|
Cost of Revenue
|
-11.7B
INR
|
Gross Profit
|
44.9B
INR
|
Operating Expenses
|
-32.2B
INR
|
Operating Income
|
12.8B
INR
|
Other Expenses
|
-2.2B
INR
|
Net Income
|
10.5B
INR
|
Free Cash Flow Analysis
Max Healthcare Institute Ltd
INR | |
Free Cash Flow | INR |
In its latest earnings call, Max Healthcare showcased impressive financial performance, achieving a 22% year-on-year revenue growth to INR 2,228 crores. Operating EBITDA grew 19% annually to INR 591 crores, with a healthy margin of 28.2%. Profit after tax improved by 13% to INR 383 crores. The company is set to expand operational bed capacity from 376 to 430 by March, targeting 480 beds by late 2025. The recent acquisition of Jaypee Hospital for INR 1,660 crores is expected to bolster growth. Max Dwarka is projected to breakeven by year-end, setting the record for the fastest in their history.
What is Earnings Call?
MAXHEALTH Profitability Score
Profitability Due Diligence
Max Healthcare Institute Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.
Score
Max Healthcare Institute Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.
MAXHEALTH Solvency Score
Solvency Due Diligence
Max Healthcare Institute Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Score
Max Healthcare Institute Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MAXHEALTH Price Targets Summary
Max Healthcare Institute Ltd
According to Wall Street analysts, the average 1-year price target for MAXHEALTH is 1 095.48 INR with a low forecast of 621.15 INR and a high forecast of 1 312.5 INR.
Dividends
Current shareholder yield for MAXHEALTH is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
MAXHEALTH Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Max Healthcare Institute Ltd. engages in the management and operation of hospitals and specialty clinics. The firm is specialized in providing treatment for cancer care / oncology, cardiac sciences, neurosciences, liver transplant and biliary sciences, orthopaedics, nephrology, kidney transplant, bone marrow transplant, bariatric/weight loss surgery and minimal access / laparoscopic surgery. Max@Home is a platform that provides health and wellness services at home and MaxLab offers pathology services to patients outside of its hospitals through a variety of channels, including third-party hospital laboratory management. The company also provides treatment for Bone marrow transplant, brain stroke treatment, brain tumor surgery, breast reduction surgery, cardiac valve replacement surgery, cataract surgery, chemotherapy, coronary angioplasty, coronary artery bypass grafting, kidney transplant, laparoscopic urologic surgery, lithotripsy, liver transplant, lung transplant, pacemaker implantation and prostate laser surgery.
Contact
IPO
Employees
Officers
The intrinsic value of one MAXHEALTH stock under the Base Case scenario is 638.32 INR.
Compared to the current market price of 999.95 INR, Max Healthcare Institute Ltd is Overvalued by 36%.